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The ETS Protein MEF Plays a Critical Role
in Perforin Gene Expression and the Development
of Natural Killer and NK-T Cells
Zuniga-Pflucker and Lenardo, 1996); NK-T cells mature
primarily in the thymus, even though extrathymic matu-
ration has been suggested (Pellicci et al., 2002), while
NK cells develop in the bone marrow. The physiologic
roles of these innate effectors are incompletely charac-
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The ETS-family of transcription factors (TFs) generallyNew York, New York 10021
cooperate with other TFs to control gene expression
(Papas et al., 1997; Sharrocks et al., 1997). The binding
sequences recognized by different ETS proteins areSummary
quite similar (usually containing a conserved GGAA cen-
tral motif), and, because most cells contain multiple ETSWe utilized gene targeting by homologous recombina-
proteins, it is difficult to determine exactly which genestion to define the role that MEF, a transcriptional acti-
are regulated by which ETS protein. Several ETS pro-vating member of the ETS family of transcription fac-
teins have been shown to be necessary for the develop-tors, plays in lymphopoiesis. MEF/ mice have a
ment of myeloid and lymphoid cells. Targeted disruptionprofound reduction in the number of NK-T and NK
of the murine PU.1 gene has shown that PU.1 is essentialcells. Purified MEF/NK cells cannot lyse tumor cell
for the generation of multiple hematopoietic lineagestargets and secrete only minimal amounts of IFN.
(McKercher et al., 1996; Scott et al., 1994a, 1994b)Perforin protein expression is severely impaired in
whereas ETS-1 knockout mice have reduced numbersMEF-deficient NK cells, likely accounting for the lack
of both NK-T and NK cells (Barton et al., 1998; Boriesof tumor cell cytotoxicity. Promoter studies and chro-
et al., 1995; Muthusamy et al., 1995).matin immunoprecipitation analyses demonstrate that
Perforin (PFP, pore-forming protein) is stored in cyto-MEF and not ETS-1 directly regulates transcription of
plasmic granules and, upon activation, NK and T cellsthe perforin gene in NK cells. Our results uncover a
secrete these cytolytic granules. PFP monomers thenspecific role of MEF in the development and function
insert into the plasma membrane of target cells andof NK cells and in innate immunity.
polymerize into pore-forming aggregates (Liu et al.,
1995), which leads to osmotic lysis, granzyme entry, andIntroduction
killing of the target cell. PFP expression is constitutive
in NK cells and is induced by IL-2 in T cells (Podack etInnate immunity plays a vital role in host defense against
al., 1991) and NK cells (generating lymphokine-activatedviral infection and tumor development; its effector cells,
killer or LAK activity). Unidentified ETS-transcription fac-NK and NK-T cells, are important for the earliest stage
tors have been described as activators (Koizumi et al.,of the immune response, which occurs without prior
1993) and silencers (Zhang and Lichtenheld, 1997) ofsensitization. NK cells are large granular lymphocytes
the perforin promoter; while the role of perforin in NK/that do not express the T cell receptor (TCR) on their
LAK-mediated cytoxicity has been well defined, its tran-
surface but can mediate perforin-dependent lysis of
scriptional regulation has not.
class-I MHC-deficient virally infected cells and tumor
MEF was cloned from a human megakaryocytic cell
cells. line and further characterized in our laboratory (Mao et
Murine NK cells are defined by the cell surface expres- al., 1999; Miyazaki et al., 2001, 1996). MEF is a member
sion of DX5 (a pan-NK cell marker) or NK1.1 (an allele- of the ETS-family of winged helix-turn-helix transcrip-
specific marker) and the lack of CD3, whereas expres- tion factors, and it is expressed in both myeloid and
sion of NK1.1 and a TCR comprised by a canonical lymphoid hematopoietic lineages. MEF is most similar
V14-J281 (Lantz and Bendelac, 1994) and a restrictive to ELF-1, which has been shown to bind to regulatory
V repertoire (V2, V7, and V8) (Bendelac, 1995; Vicari sequences in the HIV-2 LTR, the IL-2 receptor  chain
and Zlotnik, 1996) define a small subset of T cells, called promoter, and the GM-CSF and IL-3 promoters
NK-T cells, that share several characteristics with NK (Gottschalk et al., 1993; Leiden et al., 1992; Wang et al.,
cells. NK-T cells are able to recognize glycolipid anti- 1993). The homology of the MEF ETS domain with the
gens (Kawano et al., 1997) (such as -galactosylcera- ELF-1 ETS domain suggests that they may regulate simi-
mide) in the context of CD1d, a MHC class I-like mole- lar genes.
cule (Bendelac et al., 1997), and they rapidly secrete We have examined the role of MEF in lymphoid cell
large amounts of IL-4 and IFN upon activation (Arase development and function, disrupting the MEF-gene lo-
et al., 1993). NK-T cell development is far better under- cus by homologous recombination. Thymic develop-
stood than NK cell development (Moore et al., 1996; ment toward the TCR lineage is normal; however, the
number of NK-T cells is significantly reduced in the MEF-
deficient thymus. Similarly, NK cell development and4 Correspondence: s-nimer@mskcc.org
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Figure 1. Targeted Disruption of MEF Gene
(A) Schematic representation and partial re-
striction map of the wild-type locus (1), the
targeting vector (2), and the genomic region
following the correct integration of the tar-
geting construct (3).
(B) Southern blot analysis of EcoRI-digested
mouse-tail genomic DNA, probed with a 3-
external probe. The EcoRI sites are indicated
with arrows, which release the wild-type
(around 9 Kb) and targeted (around 7 Kb) frag-
ments.
(C) RT-PCR of bone marrow cells from
MEF/ and / mice, using primers com-
plementary to the exon of MEF encoding the
ETS-domain.
(D) Western blot analysis using T cells
from / and / mice and an antibody
against the MEF protein (98 KDa).
function is impaired, with a 60% reduction in the number for five generations by the time of analysis, and lit-
termate controls were used throughout the experiments.of NK cells in MEF/ spleens and defects in their
function, affecting both tumor cell cytoxicity and IFN
secretion. CD8 T cell-mediated cytoxicity, but not Normal T- and B Cell Development
in MEF-Deficient MiceCD8 T cell numbers, was also affected.
We report the impairment of PFP expression in MEF- T cell development occurs in the thymus following colo-
nization of this tissue by immigrant precursor cells,deficient NK cells and show that MEF but not ETS-1 is
bound to the promoter in vivo and transactivates the which originate in the bone marrow. These early progeni-
tors do not self-renew in the thymus; rather, they commitPFP promoter. Elderly MEF-deficient mice display poly-
clonal lymphocytic infiltrations in various organs, sug- to develop into NK-T, thymic dendritic, TCR or TCR
lineages (Godfrey and Zlotnik, 1993; Nikolic-Zugic, 1991;gesting immune dysregulation over time. Thus, MEF is
a key transcriptional regulator of innate immune cells, Shortman and Wu, 1996). This developmental pathway
starts from a minor population of CD4CD8 double-affecting the number and function of NK cells and NK-T
cell development. negative (DN) precursors (TCR) and progress
through an immature CD4CD8 double-positive stage
(TCR) to mature into either CD4CD8 or CD4CD8Results
T cells, which are then exported to the periphery (Fehling
and von Boehmer, 1997).Generation of MEF-Deficient Mice
To “knock out” the MEF gene by homologous recombi- There was no difference in thymic cellularity in young
(6–8 weeks old) MEF/ mice compared to littermatenation, two genomic fragments containing the 5-end
and 3-end of the gene were used to prepare the tar- controls, and the distribution of thymocytes in the dif-
ferent T cell populations (CD4/CD8 expression) was notgeting vector (Figure 1A). Successful targeting of the
MEF gene was determined by Southern blot (Figure 1B) grossly perturbed by the absence of the MEF gene
(Figure 2A). The DN compartment is highly heteroge-and PCR (data not shown) analysis.
MEF/ mice are born healthy and develop normally neous and can be further divided into four sequential
stages of development (DN1 → DN4) based on the ex-throughout adulthood. RT-PCR analysis demonstrates
the complete absence of MEF RNA in bone marrow cells pression of CD44 (pgp-1) (Dennert et al., 1980) and CD25
(IL-2R  chain) (Ceredig et al., 1985; Raulet, 1985):from MEF-deficient mice (Figure 1C). To demonstrate
that the targeted alleles do not produce MEF protein, CD44CD25 → CD44CD25 → CD44CD25 →
CD44CD25. Uncommitted thymocytes (DN1 andWestern blot analysis was performed using thymic ly-
sates and a species crossreacting polyclonal antibody DN2), which can differentiate into –T cells, NK-T, thy-
mic dendritic, or T cells, were present in normalraised against the human MEF protein. No detectable
MEF protein was observed in thymocytes from MEF/ numbers in the MEF/ thymus. Intrathymic T cell de-
velopment exhibits two important checkpoints: one atmice (Figure 1D), as compared to wild-type littermates.
The absence of detectable MEF RNA or protein con- the DN3 to DN4 transition (regulated by the preTCR
complex) and the second at the DN to DP transitionfirmed that the targeted mutation produced a null phe-
notype. Founder mice (mixed background C57BL/ (regulated by interactions between TCR and self-
MHC) (Fehling and von Boehmer, 1997). These check-6x129Sv) were backcrossed to a C57BL/6 background
Loss of MEF Impairs NK and NK-T Cell Function
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Figure 2. Effect of MEF on T- and B Lymphoid Cell Development and Function
(A) Effect of MEF deficiency on T cell development. The distribution of CD4/CD8 T cell subsets (top) is shown for thymocytes from 8-week-
old mice; the percentage of cells in each quadrant is indicated. The expression of CD25 and CD44 within DN cells is shown for MEF/
and / (bottom).
(B) The CD8 versus CD4 cell and TCR versus B220 profiles in the spleen are shown for MEF/ and / mice. The percentage of cells
in each quadrant is shown in each panel.
(C and D) Proliferation of unfractionated splenocytes from MEF/ and / mice induced by antigen-receptor crosslinking using anti-CD3
and anti-CD28 antibodies (C) or LPS stimulation (D). The data presented are from four independent experiments.
(E) Cytokine secretion following T cell activation. Splenocytes were stimulated in vitro for TCR crosslinking and stained for CD8 expression
(cell surface) and IL-2 or IFN (intracellular content).
(F) Cytolytic activity of MEF/ versus / CTLs. Mice (n  5) were immunized with OVA peptide in TiterMax adjuvant and the CTL response
tested by 51Cr-release assay after four in vitro stimulations. The target cells (P815-Kb) and the control (P815) cells were coated with OVA
peptide.
points are not severely affected in MEF-deficient mice, for / versus 3.1 for / spleen cells (Figure 2B). The
survival of T cells and the B cell development werealthough there is a small enhancement in the DN3 to
DN4 transition (the DN4/DN3 ratio  0.8 for / versus similar to the controls (data not shown). However, MEF-
deficient T cells showed augmented proliferation in re-1.7 for / cells) (Figure 2A), suggesting a possible role
of MEF in preTCR signaling. sponse to TCR crosslinking as measured by 3 H-thymi-
dine incorporation (Figure 2C). Similarly, MEF/Analysis of lymph nodes and spleen of MEF/ mice
revealed a modest increase in the B to T cell ratio; 4.0 splenic B cells showed a greater proliferative response
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to LPS treatment than did littermate control B cells (Fig- cells is significantly reduced (by 60%) in the spleen of
MEF/ mice compared to matched littermates (/,ure 2D). Thus, although we did not observe differences
in their development or survival, MEF/ spleen cells 1.5 	 0.3 
 106 versus /, 0.6 	 0.2 
 106 ). The
decreased numbers of NK cells in MEF/ mice areclearly displayed aberrant activation and/or prolifera-
tion. We have demonstrated that MEF has maximal ac- also evident when the expression of NK1.1 and TCR
is evaluated, as indicated by the dotted rectangle in thetivity at the G1/S phase of the cell cycle (Miyazaki et al.,
2001); thus, this increased proliferation may relate to cell middle panel of Figure 3A (spleen cells). Of note, the
lower cell surface density of NK1.1 expression on splen-cycle abnormalities that occur after cellular activation.
To assess the role of MEF in CD8 T cell function, we ocytes was observed in all mice analyzed. Although NK
cells secrete IFN in response to viral nucleic acidsanalyzed cytokine secretion in response to TCR cross-
linking and the ability of CD8 T cells to specifically lyse such as poly I:C (polyinosinic-polycytidylic acid), IFN
secretion was detected in only 3% of MEF/ DX5antigen-bearing target cells. As shown in Figure 2E, the
percentage of MEF/ CD8 T cells secreting IL-2 and cells compared to 20% of DX5 MEF/ NK cells (Fig-
ure 4B). IFN secretion was measured using total splen-IFN is similar to wild-type CD8 T cells. CD8 T cells
can kill through two pathways; the predominant method ocytes, so we assessed the possibility that MEF/
macrophages provide inadequate stimulus to the NKis PFP dependent and the second pathway is via Fas-
FasL interactions. To examine cytoxicity, we immunized cells; we stimulated MEF/macrophages with polyI:C
and found normal levels of IL-12 expression by intracel-MEF/ and MEF/ mice with OVA257-264 peptide and
then restimulated the cytotoxic T cell lymphocytes (CTL) lular staining (data not shown). Thus, the lower IFN
secretion observed in MEF/ splenocytes is not duein vitro prior to testing for lytic activity. CTLs derived
from MEF/ mice were significantly impaired in their to a lack of stimulatory signals, but rather reflects an
intrinsic inability of MEF/ NK cells to produce thisability to lyse target cells coated with the OVA257-264 pep-
tide, requiring approximately 5- to 10-fold more cells to cytokine. Thus, the few DX5CD3 cells found in MEF
null mice are functionally impaired, demonstrating theachieve the same degree of killing (Figure 2F). This result
indicates that genes critically involved in cytolytic mech- dual effects of MEF deficiency on NK cell development
and NK cell function.anisms are regulated by MEF.
To further define whether the developmental abnor-
malities of NK-T and NK cells are cell intrinsic or areMEF Is Required for NK-T and NK Cell
due to a “neglecting” milieu, we performed bone mar-Development and Function
row transplant experiments using either MEF/ orWe next evaluated the role of MEF in NK-T and NK cell
MEF/ bone marrow cells to reconstitute wild-typedevelopment and function. Murine NK-T cells (TCR
recipients (see Supplemental Table S1 at http://www.NK1.1 and either CD4CD8 or CD4CD8) develop
immunity .com/cgi /content / full /17 /4 /437/DC1 ) . NKprimarily in the thymus. To evaluate NK-T cell develop-
and NK-T cells derived from MEF/ bone marrow pro-ment, we examined thymocytes and lymphocytes from
genitors were consistently underrepresented comparedthe spleen and liver for the cell surface markers NK1.1
to wild-type bone marrow in the tissues analyzed,and TCR by flow cytometry. As shown in Figures 3A
thereby reproducing the phenotypic impairment ob-and 3B, we observed a significant reduction (70%) in
served in MEF/ mice. Thus, the NK developmentalthe numbers of NK1.1 TCR cells in the thymus
abnormalities seen in MEF/ mice are due to intrinsic(/, 0.82 	 0.20 
 106 versus /, 0.25 	 0.17 
 106 ),
cellular defects caused by the absence of this transcrip-and in the spleen and liver of MEF/ mice, suggesting
tion factor.that MEF expression is needed for thymic NK-T cell
NK cells play an important role in tumor surveillance,development. NK-T cells use an invariant TCR  chain
preventing tumor formation of malignant cells. Many(V14) (Koseki et al., 1991; Lantz and Bendelac, 1994), so
tumor cells downregulate cell surface expression ofwe further analyzed NK-T cell numbers in MEF-deficient
MHC, so in order to kill them, NK cells must be able tothymocytes using a semiquantitative RT-PCR, which
recognize MHC class I-deficient cells, become acti-showed a significant reduction in the level of V14 tran-
vated, and secrete perforin-containing granules, in orderscripts (Figure 3C).
to trigger lysis of the tumor cells. We examined NKTo assess NK-T cell function, NK-T cells were purified
cell cytotoxicity in a chromium release assay, utilizingfrom MEF/ and / mice by cell sorting, using the
purified DX5CD3 NK cells (by cell sorting) as effectorNK1.1 and TCR markers. NK-T cells but not naive T
cells and RMA-S cells as the target. As shown in Figurecells are known to express IL-4 in response to TCR-
4C, MEF/ NK cells were unable to kill tumor cellcrosslinking (Arase et al., 1993), so this was done. As
targets, whereas wild-type NK cells showed normal cy-shown in Figure 3D, MEF/ thymocytes have a nearly
tolytic capacity (following poly I:C stimulation in vivo).normal capacity to produce IL-4; therefore, the lack of
IL-2 is known to induce NK cell cytotoxicity; however,MEF does not impact significantly on NK-T cell cytokine
as shown in Figure 4D, addition of IL-2 for 20 hr onlysecretion.
partially restored the cytolytic capacity of MEF/ NKWe then examined the role of MEF deficiency on NK
cells (to 30% of the activity of the MEF/ NK cells).cell development, as these cells also play a vital role in
The diminished IFN secretion in response to poly I:Cinnate immunity and exhibit properties similar to NK-T
stimulation and the inability to lyse MHC class I-deficientcells. We identified NK cells from the spleens of MEF
cells suggests a key role of MEF in regulating the expres-null and wild-type mice, using antibodies against DX5
sion of genes required for these NK cell functions (cyto-and against CD3. As shown in Figure 4A, the percent-
age as well as the absolute number of DX5CD3 NK kine secretion and cell lysis).
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Figure 3. Paucity of NK-T Cells in MEF-Deficient Mice
(A) Lymphocytes from thymus, spleen, and liver of MEF/ and / mice were analyzed for their cell surface expression of NK1.1 and
TCR. Percentages of NK1.1TCR (NK-T) cells are indicated for each gate of a representative experiment. NK1.1TCR (NK) cells are
indicated by a dotted rectangle in the second row of dot-plots (containing spleen cells).
(B) Numbers of NK-T cells per thymus of MEF/ versus MEF / mice are shown on the right (P  0.0004, paired t test).
(C) Expression of V14-J281 mRNA in spleen cells from MEF/ and wild-type was assessed using a semiquantitative RT-PCR. Serial
dilutions for the cDNA are shown for V14-J281 and -actin gene.
(D) IL-4 production by purified NK-T cells was measured following TCR crosslinking. The intracellular levels of IL-4 were determined after 48
hr of stimulation.
Defective Perforin Gene Expression tein expression (Figure 5C). This result was confirmed
using purified NK cells (data not shown). The flow cytom-in MEF-Deficient NK Cells
Having defined both quantitative and qualitative defects etry also shows the reduced numbers of IL-2R dim/
negative cells (Figure 5C), which reflects the NK cellin MEF/ NK cells, we further characterized the func-
tional activities of these cells. To show that MEF-defi- population (resting NK cells are known to express c,
IL-15R, and IL-15R but not IL-2R). The c, IL-15R,cient NK cells are capable of binding to the tumor target
cell, we used flow cytometry and CFSE-labeled RMA-S and IL-15R mRNAs are expressed at nearly normal
levels in MEF-deficient splenocytes; thus, the modestcells incubated with purified NK cells (DX5 CD3).
MEF/ NK cells form a normal NK cell:RMA-S cell impairment in IL-2R and IL-15R expression does not
seem sufficient to explain the functional impairmentscomplex, after a brief incubation with CFSE-labeled
RMA-S cells (Figure 5A). observed. Given the vital role of perforin in the direct
cytolysis of tumor cells by activated NK cells, we exam-To determine whether the NK-cell functional impair-
ments are due to an inability to perceive environmental ined its expression.
Immunostaining of purified MEF/NK cells revealedsignals, we examined cytokine receptor expression on
MEF/ splenocytes, mainly focusing on the multisub- little or no PFP in the granules (Figure 5D), and the level
of PFP protein expression in total splenocytes incubatedunit IL-2 and IL-15 receptor complexes. RNase protec-
tion assays showed a slight reduction in the level of IL- for 16 hr with IL-2 was approximately 20% of normal
(Figure 5E). We next measured the intracellular level of2R and IL-2RmRNA expression (87% and 92% of the
wild-type level, respectively) (Figure 5B), whereas flow PFP in unstimulated NK1.1 cells and in IL-2-stimulated
CD8 T cells (Figure 5F). The NK cells but not the CD8cytometry also showed a mild reduction in IL-2R pro-
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Figure 4. NK Cell Development and Function Is Impaired by MEF Deficiency
(A) Flow cytometric analysis of lymphocytes using anti-DX5 and anti-CD3 antibodies. The percentage of DX5CD3 cells from a representative
experiment is shown on the left and the number of NK cells per spleen is shown on the right. The Student’s t test was used for comparative
analysis (P  0.0002).
(B) Wild-type and MEF-deficient DX5 splenocytes were stimulated in vitro with poly I:C for 18 hr, and IFN was measured by intracellular
staining and flow cytometric analysis.
(C) In vitro cytoxicity using purified NK cells (DX5CD3) from MEF/ and MEF/ mice injected with poly I:C the day before and the
RMA-S cell line as target. Three independent experiments were performed; results from two mice per genotype are shown for a representative
experiment.
(D) In vitro cytoxicity of purified NK cells incubated in the presence or absence of IL-2 (20 ng/ml) for 16–20 hr prior to performing the cytotoxicity
assay.
T cells showed markedly reduced PFP expression, sug- in NK cells versus CTLs. Lack of MEF has a greater
impact on constitutive PFP expression by cells involvedgesting that MEF is essential for PFP expression in natu-
ral killer cells but not in activated CD8 T cells. Distinct in innate immunity than on inducible PFP expression by
cells in the adaptive arm of the immune system. Thus,patterns of gene expression have been reported in these
populations (Wilson and Byrne, 2001), reflecting their the relative inefficiency of MEF/ CTLs in killing anti-
gen-specific targets is likely due to features other thandifferent regulatory controls, and our results indicate
distinct transcriptional regulation of perforin expression a lack of perforin.
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Figure 5. Cytokine Receptor and Perforin Expression in MEF-Deficient NK Cells
(A) Binding of MEF/ or MEF/ NK cells to tumor cells. CFSE-labeled RMA-S cells were incubated with DX5CD3 NK sorted cells for
5 min at 37C and then immediately shifted to 4C until analysis. The DX5 (NK cells) versus CFSE (target) profile is shown; the gate shows
the presence of NK cell:RMA-S cell conjugates.
(B) RNase protection assay using total splenocytes stimulated with poly I:C. The probes used are shown on the right and the percentage of
receptor expression in MEF/ splenocytes compared to the control is indicated (the arrows indicate the receptors whose expression has
been quantified).
(C) Expression of IL-2R and IL-2R chains on DX5 splenocytes obtained from wild-type (bold line) or MEF-deficient mice (filled line).
(D) Immunocytochemistry of purified NK cells using an anti-PFP antibody. The arrows indicate PFP-granules in the wild-type NK cells.
(E) Western blot analysis of total splenocytes (from MEF/ versus / mice) previously stimulated for 16 hr with IL-2 (2 U/ml). Detection
of PFP and -actin proteins is shown.
(F) Intracellular staining of perforin using freshly isolated splenocytes demonstrates lower perforin expression in NK1.1 MEF/ cells than
wild-type cells, but normal expression in IL-2 stimulated CD8 T cells.
MEF Regulates Perforin Promoter Activity moter (using the P1, 1366 or the P2, 1136 promoter
constructs) (Yu et al., 1999) in Cos cells (Figure 6A) andTo determine whether the PFP gene is directly regulated
by MEF, we used a luciferase gene reporter system to in the CTLL-2 cytotoxic T cell line (10-fold induction,
data not shown). In contrast, neither PU.1 nor ETS-1examine whether MEF can transactivate the human PFP
promoter. MEF strongly activates the human PFP pro- activates the human PFP promoter. There are two con-
Immunity
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Figure 6. The Perforin Promoter Is Regulated by MEF
(A) Transcriptional activation of the human PFP promoter by MEF. COS cells were cotransfected with the indicated hPFP-luciferase reporter
gene and CMV-promoter-based expression plasmids containing the human MEF, PU.1, or ETS-1 cDNA. The data presented are the aggregate
of four independent experiments.
(B) EMSA using probes for ETS binding sites (EBS) at –43 (EBS1, lanes 1–5) and –497 (EBS2, lanes 6–10) of mouse PFP promoter. In the
mutant probes (EBSm), the core binding –GGAA- was replaced by –CCAA- (lanes 3 and 8). The anti-MEF antibody blocked the specific binding
to both sites (lanes 4 and 9). Rabbit reticulocyte lysate control is shown in lanes 5 and 10.
(C) EMSAs demonstrating that in vitro-translated ETS-1 binds to an ETS binding site in the IL-3 promoter (lane 1) but not to the EBS1 (lanes
4–6) or EBS2 (lanes 8–10) sites in the murine perforin promoter. MEF binding to the EBS1 (lane 3) and EBS2 (lane 7) sites was also confirmed.
(D) Chromatin immunoprecipitation analysis of MEF binding to PFP promoter in the PFP-positive CTLL-2 cell line but not the PFP-negative
EL-4 cell line. Formaldehyde-crosslinked chromatin from EL-4 and CTLL-2 cells was immunoprecipitated using nonimmunized rabbit serum
(IgG control) or affinity purified anti-MEF antibody. PCR was then performed on the input DNA and the immunoprecipitated DNA, using primer
pairs spanning MEF binding site 1 (EBS1) and site 2 (EBS2). The control lane represents a PCR reaction conducted in the absence of template
DNA. The intensity of the band corresponding to immunoprecipitation with the anti-MEF antibody is expressed as fold increase compared to
the corresponding control (nonimmunized rabbit serum).
sensus ETS binding sites (EBS) in the mouse promoter; protein blocks the binding of MEF to both ETS sites
in the PFP promoter (lanes 4 and 9). ETS-1 has beenone is adjacent to the guanine/cytosine box at position
–43 (EBS1) and the second is located at position –497 previously reported to play an important role in NK cell
development; therefore, we tested the ability of ETS-1(EBS2); these sites correspond to positions –34 and –610
in the human promoter (Lichtenheld and Podack, 1992; protein to bind to the PFP promoter. As shown in Figure
6C, ETS-1 failed to bind to either ETS binding site in theYu et al., 1999). To determine whether MEF can bind
directly to these sites, we performed a series of EMSAs murine PFP promoter (lanes 4–6 and 8–10), whereas
ETS-1 efficiently bound to the ETS binding site in theusing double-stranded oligonucleotide probes that con-
tain a single ETS binding site (EBS1 or EBS2) and mini- IL-3 promoter (lane 1), as previously described (Nimer
et al., 1996). Collectively, the data demonstrate that al-mal flanking sequences. As shown in Figure 6B, MEF
binds to both the downstream (EBS1, lanes 1–5) and though both MEF (our results) and ETS-1 (Barton et
al., 1998) are important in NK cell development, MEFupstream (EBS2, lanes 6–10) ETS sites, in a sequence-
specific fashion. The presence of a 150-fold molar ex- specifically regulates PFP gene expression in natural
killer cells.cess of unlabeled wild-type oligonucleotide (NGGAAN)
eliminated the binding of in vitro-translated MEF protein Furthermore, to determine whether these ETS sites
bind endogenous MEF protein in cells expressing PFP,(lanes 2 and 7), whereas unlabeled mutated oligonucleo-
tides that lack the ETS binding site (NCCAAN) do not we performed chromatin immunoprecipitation (ChIP)
experiments using an affinity-purified anti-MEF antibody(lanes 3 and 8). Furthermore, an antibody against MEF-
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Figure 7. MEF Deficiency Leads to Lymphoid
Infiltrates in Old Mice
Representative lymphocytic infiltrations ob-
served in MEF null (/) mice involving the
kidney (A–D) and the lung (E–H). Hematoxylin-
eosin-stained sections at a magnification of
100
 (A and E) and 400
 (B and F). Immuno-
histochemistry was performed using an anti-
CD3 antibody as a marker of T cells ([D] and
[H] at 400
magnification) and anti-B220 anti-
body as a B cell marker ([C] and [G] at 400

magnification).
and the CTLL-2 and EL-4 cell lines. PCR analysis, per- cient mice and FHL patients. Histological examination of
older MEF/ mice often demonstrates a lymphocyticformed on DNA prepared from immunoprecipitated
chromatin using primers spanning the PFP gene (sites infiltration that is not seen in wild-type or heterozygous
mice (Figures 7A, 7B, 7E, and 7F). These infiltrates areEBS1 and EBS2), detected endogenous MEF-protein
bound to both EBSs in CTLL-2 cells (Figure 6D), which particularly prominent around blood vessels in the lung
and kidney, but they involve other tissues as well, suchconstitutively express PFP, but not in EL-4 cells, which
do not express PFP (but which do contain MEF protein). as the myometrium of the uterus. The perivascular
lymphocytic infiltration strongly resembles those foundThe ChIP assay did not detect binding of ETS-1 to the
perforin promoter in either cell line (data not shown). in FHL patients (Fadeel et al., 2001). They are comprised
of both T cells and B cells, based on anti-CD3 (FiguresThese results confirm previous preliminary observa-
tions, indicating that an ETS protein (which is neither 7D and 7H) and anti-B220 staining (Figures 7C and 7G),
and they do not generally appear until 1 year of age.ETS-1 nor ELF-1) regulates perforin gene expression
(Koizumi et al., 1993). Our in vivo and in vitro data identify MEF null mice (beyond 1 year old) also occasionally
exhibit enlargement of secondary lymphoid organs (dataMEF as a key regulator of activation-independent per-
forin gene expression (in NK cells). not shown), suggesting that lack of MEF may lead to
dysregulation of the immune system over time due to
the NK, NK-T, and CTL numerical and/or functional de-MEF-Deficient Mice Exhibit Multiorgan
fects that we observed.Lymphocyte Infiltrates
Mutations in the human PFP gene have been found in
patients with familial hemophagocytic lymphohistio- Discussion
cytosis (FHL), who exhibit NK cell dysfunction and im-
mune dysregulation (Stepp et al., 1999, 2000). Therefore, Detailed analyses of nullzygous mice that lack specific
ETS genes have been reported for 5 of the more thanwe looked for phenotypic similarities between MEF-defi-
Immunity
446
20 members of the ETS-family of TFs, including PU.1 Pellicci et al., 2002) have used CD1d/-galactysylcera-
mide tetramers to show that thymic TCRNK1.1 cells(Iwama et al., 1998; Scott et al., 1994a), ETS-1 (Bories
et al., 1995; Muthusamy et al., 1995), Spi-B (Su et al., are the precursors of TCRNK1.1 cells. One model
(Benlagha et al., 2002) proposes that the NK-T precur-1997), Fli1 (Hart et al., 2000), and TEL (Wang et al., 1997).
PU.1 (Spi-1) has been shown to exhibit partial functional sors branch off the main T cell developmental pathway
at the CD48 stage; this model would suggest that theredundancy with Spi-B but not with ETS-1 or ELF-1
(Garrett-Sinha et al., 2001), despite their relatively similar impairment observed in MEF/ mice occurs at this
stage. Targeted deletion of ETS-1 gives a similar pheno-consensus DNA binding sequences. MEF is an ETS pro-
tein that is expressed in both myeloid and lymphoid type (Walunas et al., 2000), implying that MEF and ETS-1
may work together in the commitment of NK/T progeni-hematopoietic cells and shares significant homology to
ELF-1 and NERF. MEF is a stronger transcriptional acti- tor cells to the NK-T cell versus the T cell lineage. Of
note, very low levels of ETS-1 (and ELF-1) mRNA havevator on several hematopoietic gene promoters than
ELF-1 (Miyazaki et al., 1996), and MEF may play a role been detected by RT-PCR in pre-NK thymic precursors
(Kanakaraj et al., 2001), demonstrating that these tran-in innate immunity by regulating the expression of lyso-
zyme in epithelial cells at mucosal surfaces (Kai et al., scription factors could play a role in NK-lineage commit-
ment at this developmental stage.1999). ELF-1-deficient mice have been generated; they
are viable and do not have abnormalities in their hemato- NK cells develop entirely in the bone marrow from
NK-progenitors (Lin Sca-1 c-kit Flt3), and SCF, Flt3poietic cell development (Garrett-Sinha et al., 2001). To
define the role of MEF in lymphoid development and ligand, and IL-7 are required early to induce proliferation
and IL-15R  chain expression. IL-15, which is producedcellular behavior, we generated MEF null mice using
homologous recombination. by the bone marrow stroma, drives the final maturation
process (Cooper et al., 2001). Defects in NK cell develop-The absence of embryonic lethality or severe develop-
mental abnormalities in MEF/mice suggests that the ment due to the lack of interferon regulatory factor 1
(IRF-1) occur because IRF-1 is needed for stromal cellpresence of other members of the ETS-family, perhaps
ELF-1 and NERF, provide sufficient common activity to production of IL-15. In contrast, the defect in MEF/
mice is cell intrinsic, as conclusively shown by the boneallow development to proceed without profound de-
fects. The phenotype of the ETS-1 knockout mouse marrow transplant experiments. We detected normal
levels of IL-15R  chain in MEF/ NK cells, and thusdemonstrates that the functional overlap of ETS TFs in
hematopoiesis can lead to normal development, al- far we have not identified a significant defect in cytokine
receptor expression in MEF/ NK cells.though the homeostasis of a specific lineage can be
more severely affected. The inability of MEF/ NK cells to lyse tumor cells
that lack class I MHC expression, secrete IFN, andMEF is not required for the development of mature T
and B cells. Although PU.1/ mice exhibit a block in express PFP suggests that MEF-mediated transcrip-
tional regulation is important for both NK-cell develop-T cell differentiation prior to T cell commitment (Spain
et al., 1999), MEF/ mice have no major change in ment and function. IFN plays a role in both the innate
and adaptive arms of host immune defense, and perforinintrathymic T cell development. However, MEF/
splenocytes have increased proliferative capacity in re- and IFN work synergistically to eradicate tumors in
models where innate immunity plays an important rolesponse to TCR or LPS stimulation. Increased prolifera-
tion in response to TCR activation has also been shown (Street et al., 2001). Recently, increased expansion of
antigen-specific CD8 T cells has been described forfor PU.1/ fetal thymic organ cultures (Spain et al.,
1999), whereas ETS-1/ T cells display a severe prolif- PFP- and IFN-deficient mice, leading to a larger CD8 T
cell memory pool (Badovinac et al., 2000). The selectiveerative defect in response to TCR crosslinking (Muthu-
samy et al., 1995). These distinct phenotypes most likely impairment of PFP and IFN expression in MEF/ NK
cells suggests that MEF/ mice may be useful forreflect specific cell cycle effects of these TFs, following
cellular activation. MEF is known to be cell cycle regu- delineating the role of NK cells in lymphoid homeostasis.
The role of PFP in downregulating the immune responselated, with maximal activity at G1 phase. Cyclin A physi-
cally associates with MEF and the cyclin A/cdk-2 com- in vivo, by perforin-dependent activation-induced cell
death (AICD) (Kagi et al., 1999), may explain the tissueplex phosphorylates residues located in its C terminus
(Miyazaki et al., 2001). MEF is then targeted for ubiquiti- infiltration seen in MEF/ mice.
We have also observed functional defects in activatednation and proteosomal degradation (S.M. et al., unpub-
lished data). Loss of MEF could prime entry into S phase, CD8 T cells obtained from MEF-deficient mice. Peptide
immunization of these mice can generate a specific Tpossibly explaining the dysregulated activation-induced
proliferation of MEF-deficient lymphoid cells. cell response, although the cytolytic capacity of the
MEF/ CTLs is weaker than that seen with wild-typeA common T/NK progenitor cell has been identified
in the murine thymus, which is derived from the common CTLs. The relatively normal PFP expression by CD8 T
cells indicates that target genes other than PFP are likelylymphoid progenitor cell (CLP) (Sanchez et al., 1994).
Thymic development of NK-T cells appears to be most involved in the process. PFP expression is constitutive
in NK cells but not in CTLs; the requirement for MEF mayseverely impaired by the absence of MEF, reflected in
the profound decrease in NK-T cells in the liver of not be absolute in CD8 T cells undergoing activation.
Approximately 20% of the FHL patients, who exhibitMEF/mice. Bone marrow-derived thymic progenitor
cells are found in normal numbers in the MEF-deficient NK cell dysfunction and immune dysregulation, display
mutations in the PFP gene (Stepp et al., 1999, 2000).thymus, implying that MEF is crucial for a more down-
stream event, i.e., the lineage choice between NK-T and These children develop lymphocytic tissue infiltration,
splenomegaly, and an accumulation of activated T lym-T cells. Recently, two groups (Benlagha et al., 2002;
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prior to performing the proliferation assay. [3H]-thymidine incorpora-phocytes, somewhat similar to MEF-deficient mice. PFP
tion was measured in sextuples.deficiency in humans gives rise to a rapidly fatal immune
dysregulation, whereas PFP-deficient mice may be
Intracellular Staining of Cytokines
“healthy” in a pathogen-free environment. The basis for Splenic cells were incubated for 18 hr at 37C in the presence of
FHL in patients lacking PFP gene mutations remains 100 g/ml of poly (I:C) (Sigma) or anti-CD3 (plate bound) and CD28
unknown; however, deficient MEF activity could gener- in the media; brefeldin A was added for the last 4 hr. Then, cells
were fixed and permeabilized using the Cytofix/Cytoperm plus kitate immune dysregulation, similar to that seen in FHL.
(Pharmingen), and the intracellular levels of IFN or IL-2 were deter-The absence of MEF affects innate immunity by alter-
mined by flow cytometry using a PE-conjugated antibody. Toing the development and function of NK and NK-T cells
measure IL-4 secretion, thymocytes were incubated overnight on
and impairing perforin gene expression in natural killer anti-CD3-coated plates in the presence of brefeldin A and then
cells. Further studies are ongoing to evaluate tumor re- processed as described for IFN.
jection, graft rejection, and immunity against viral infec-
tions in MEF-deficient mice. NK Cell Cytotoxic Assay
DX5CD3 cells were purified by cell sorting from the spleen of
mice previously injected i.p. with 100 g poly (I:C) (Sigma), or PBSExperimental Procedures
as control. Target cells (RMA-S) were labeled with 100 Ci sodium
[51Cr]-chromate for 1 hr at 37C and washed three times beforeMice
plating them (2 
 104/well) in the presence of different concentra-To knock out the MEF gene by homologous recombination, we
tions of purified NK cells. Target cell lysis was allowed to proceedisolated MEF genomic clones from a mouse genomic library using
for 4 hr at 37C, and the supernantant was counted using Packardthe murine MEF cDNA as a probe. The MEF gene is located on the X
 counter. The percentage of specific lysis was calculated as: [ex-chromosome (Xq26); therefore its mutation will lead to homozygous
perimental 51Cr release  spontaneous release (no effector cells)]/female and hemizygous male null mice. Two genomic fragments
[maximum release  spontaneous release]. Maximum release wascontaining the 5-end (4–5 kb including exon 1) and the 3-end (4.5
measured by adding 1% Triton X-100, whereas spontaneous releasekb) of the gene were used to prepare the targeting vector that
was measured by omitting the effector cells.replaces most of the MEF-coding sequences, including the ETS
domain, with the neomycin-resistance gene (neo) cassette. CJ7 ES
CTL Assay(129S1/Sv strain) cells were electroporated with the targeting vector,
CTLs were generated from MEF/ and wild-type mice by peptideselected for ganciclovir and G418 resistance and injected into
immunization involving footpad injection of an emulsion of TiterMaxC57BL/6 blastocysts by our Core Transgenic Facility. Successful
(Sigma) and OVA257-264 peptide. The CTLs were weekly restimulatedtargeting of the MEF gene was determined by Southern blot and
in vitro, at least four times, using OVA-pulsed spleen cells. ThePCR analysis. All mice were analyzed at 6–12 weeks of age (unless
cytotoxic activity of CD8 cells was evaluated using the 4 hr chro-otherwise specified).
mium-release assay, as described above, using P815 cells trans-
fected with MHC Kb and pulsed with OVA peptide, as the target.
RNA and PCR Analysis These assays were repeated for four times for each MEF/ and
RNA was extracted using the RNAzol method, and the cDNA was
/ (n  4).
synthesized using the Stratagene kit (La Jolla, CA). PCR was then
performed using primer oligonucleotides complementary to the se-
Measurement of Promoter Activity
quences in the 5 and 3of: MEF (5-TGATATCCACCAGCTGGAAGA-
COS cells were electroporated (960 F and 250V) with 1 g of a
3 and 5-GTAGATTGATGGCCTGAACAG-3), V14 (5-CTAAGCA
reporter plasmid containing the human perforin promoter cloned
CAGCACGCTGCACA-3 and 5-AAGTCGGGTGAACAGGCAGAGG-
upstream of the luciferase gene, 5 g of a CMV5-MEF expression
3), and the -actin primers purchased from Stratagene. Amplifica-
plasmid (or the empty CMV5 vector), and 0.2g pRLCMV containing
tion was performed at an annealing temperature of 55C for 30
Renilla luciferase gene as control of transfection efficiency. After 48
cycles. Following amplification, the reaction mixture was resolved
hr, cells were lysed and promoter activity measured using the dual-
on a 1.3% agarose gel with ethidium bromide staining. RNase pro-
luciferase reporter assay system (Promega). Data were normalized
tection assays were performed using the kit provided by Phar-
for transfection efficiency and expressed in arbitrary RLU units.
mingen.
Electrophoretic-Mobility Shift Assay
Flow Cytometry Analysis Following the procedure previously described by our laboratory
Anti-CD4, CD8, CD44, CD25, TCR (mAb H57-597), NK1.1, DX5, (Miyazaki et al., 1996), we synthesized complementary oligonucleo-
CD19, IFN, IL-4, and B220 antibodies (Abs) were obtained directly tides that contain sequences from the mouse perforin promoter
conjugated from Pharmingen (San Diego, CA). Single-cell suspen- located between 34 bp and –63 bp (EBS1: TCTGGGGGCAGGG
sions were preincubated with CD16/CD32 (Pharmingen) and stained CAGGAAGTAGTAATGAT) and between –489 bp and –519 (EBS2:
with the indicated Abs, and 30 
 104 cells/sample were analyzed GTAGGTATGGACAGGAAGTGGGTACCAGCT). Similar complemen-
using a FACScan (Becton Dickinson, Mountain View, CA) cytometer. tary oligonucleotides were synthesized containing mutated ETS
The data were then analyzed using CellQuest 3.1 software. binding sites, including nucleotide substitutions in the binding site
to NCCAAN. Both strands of these oligonucleotides were annealed,
labeled using polynucleotide kinase and [32P-]-ATP, and incubatedProliferation Assay
with rabbit reticulocyte lysate or in vitro-translated MEF or ETS1.Splenocytes from MEF/ and littermate controls were stimulated
by either TCR crosslinking or LPS treatment. To crosslink the TCR,
sterile polyvinyl chloride microtiter plates (Fisher Scientific, Pitts- Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assays were performed us-burgh, PA) were coated overnight at 4C with 200 l/well of anti-CD3
antibody (clone 2C11) at the concentrations indicated in carbonate- ing the ChIP assay kit, purchased from Upstate Biotechnology.
CTLL-2 cells and EL-4 cells were used to assess the binding ofbicarbonate buffer, pH 9.6. Plates were then washed and blocked
with complete media, and 1 
 105 spleen cells were added per well MEF to the EBS in the PFP promoter. Cells were crosslinked with
formaldehyde and the isolated nuclei were sonicated using a sonicin the presence of anti-CD28 (3 g/ml) and incubated for 3 days.
Proliferation was measured by [3H]-thymidine (10 Ci/well) for 10 dismembrator (Fisher Scientific, Model 500) to generate a mean
DNA size of 300 bp average. Chromatin was incubated with nonim-additional hours. Cells were harvested and thymidine incorporation
was determined by scintillation counting using a top-count Packard munized rabbit serum or affinity-purified anti-MEF. DNA was purified
from the washed chromatin immunoprecipitate by phenol/chloro- counter (Packard Instruments, Downers Grove, IL). LPS was added
at a concentration of 10 g/ml and incubated with cells for 3 days form extraction and ethanol precipitation following the crosslink
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reversal and proteinase K digestion. Input and immunoprecipitated fects of cytotoxic monoclonal antibody specific for T200 glycopro-
tein on functional lymphoid cell populations. Cell. Immunol. 53,DNA were analyzed by PCR (30 cycles) with primer pairs spanning
each of the EBS present in the proximal perforin promoter [(EBS1: 350–364.
TCACAGCTGACTTCCTGAAGG and CAGGGTATCTCAACCTCCCTG, Fadeel, B., Orrenius, S., and Henter, J.I. (2001). Familial hemophago-
271 bp) and (EBS2: ACAGTAACCTCAGGCAGAACA and TCCTCCC cytic lymphohistiocytosis: too little cell death can seriously damage
TGGGAGTGGGGAGA, 140 bp)]. For quantitation, 0.5 l of -32P your health. Leuk. Lymphoma 42, 13–20.
dCTP was added to the PCR reactions, and the products were
Fehling, H.J., and von Boehmer, H. (1997). Early  T cell develop-
resolved on a 10% TBE polyacrylamide gel and visualized by autora-
ment in the thymus of normal and genetically altered mice. Curr.
diography.
Opin. Immunol. 9, 263–275.
Garrett-Sinha, L.A., Dahl, R., Rao, S., Barton, K.P., and Simon, M.C.Western Blot Analysis
(2001). PU.1 exhibits partial functional redundancy with Spi-B, butDetergent lysates from freshly isolated cells were analyzed on SDS-
not with Ets-1 or Elf-1. Blood 97, 2908–2912.PAGE, transferred to Hybond-ECL (Amersham), and blotted with
Godfrey, D.I., and Zlotnik, A. (1993). Control points in early T-cellanti-MEF polyclonal serum followed by anti-rabbit HRP. For PFP
development. Immunol. Today 14, 547–553.detection, an anti-PFP antibody (Alexis) and IL-2 stimulated spleno-
cytes were used. Finally, blots were developed using ECL-plus kit Gottschalk, L.R., Giannola, D.M., and Emerson, S.G. (1993). Molecu-
(Amersham). Equal protein loading in each lane was ensured by lar regulation of the human IL-3 gene: inducible T cell- restricted
using anti -actin antibody. expression requires intact AP-1 and Elf-1 nuclear protein binding
sites. J. Exp. Med. 178, 1681–1692.
Histopathology Hart, A., Melet, F., Grossfeld, P., Chien, K., Jones, C., Tunnacliffe,
Tissues were fixed in 10% buffered formalin and embedded in paraf- A., Favier, R., and Bernstein, A. (2000). Fli-1 is required for murine
fin, and five microns sections were stained with hematoxylin and vascular and megakaryocytic development and is hemizygously de-
eosin. For immunohistochemical studies using anti-CD3 and anti- leted in patients with thrombocytopenia. Immunity 13, 167–177.
B220, sections were deparaffinized, rehydrated in graded alcohols,
Iwama, A., Zhang, P., Darlington, G.J., McKercher, S.R., Maki, R.,
and processed using the avidin-biotin peroxidase technique (Vector
and Tenen, D.G. (1998). Use of RDA analysis of knockout mice to
Laboratories, Inc., Burlingame, CA). Diaminobenzidine was used as
identify myeloid genes regulated in vivo by PU.1 and C/EBP. Nu-
the chromogen and hematoxylin as the nuclear counterstain.
cleic Acids Res. 26, 3034–3043.
Kagi, D., Odermatt, B., and Mak, T.W. (1999). Homeostatic regulationAcknowledgments
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